Substrate Imaging to Guide Primary Prevention Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy Fanciful or Realistic Aim? COMMENT

被引：1
|
作者：
Gupta, Ankur [1 ]
机构：
[1] Henry Ford Hosp, Dept Internal Med, Div Cardiol, Detroit, MI 48202 USA
来源：
JACC-CARDIOVASCULAR IMAGING | 2020年 / 13卷 / 08期
关键词：
cardiac magnetic resonance; implantable cardioverter-defibrillator; positron-emission tomography; ventricular arrhythmia; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; RISK; PREDICTS; SHOCKS; HEART; SCAR; CMR;
D O I：
10.1016/j.jcmg.2020.05.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1767 / 1770
页数：4
相关论文
共 50 条
  • [21] Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy
    Pathak, Rajeev K.
    Sanders, Prashanthan
    Deo, Rajat
    EUROPEAN HEART JOURNAL, 2018, 39 (31) : 2859 - +
  • [22] Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction
    Baman, Jayson R.
    Patil, Kaustubha D.
    Medhekar, Ankit N.
    Wilcox, Jane E.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 585 - 596
  • [23] Gender Differences in Implantable Cardioverter-Defibrillator Utilization for Primary Prevention of Sudden Cardiac Death
    Dahiya, Garima
    Chen, Jane
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (12)
  • [24] Primary prevention implantable cardioverter-defibrillator implantation in elderly patients: is it justified to withhold treatment?
    van der Heijden, Aafke C.
    van Erven, Lieselot
    Schalij, Martin J.
    Borleffs, C. Jan Willem
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (07) : 787 - 789
  • [25] Prognostic value of noninvasive programmed stimulation in primary prevention implantable cardioverter-defibrillator recipients
    Futyma, Piotr
    Santangeli, Pasquale
    Zarebski, Lukasz
    Wrzos, Aleksandra
    Sander, Jaroslaw
    Futyma, Marian
    Marchlinski, Francis E.
    Kulakowski, Piotr
    JOURNAL OF ARRHYTHMIA, 2024, 40 (03) : 578 - 584
  • [26] Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
    Rahmawati, Anita
    Chishaki, Akiko
    Ohkusa, Tomoko
    Sawatari, Hiroyuki
    Tsuchihashi-Makaya, Miyuki
    Ohtsuka, Yuko
    Nakai, Mori
    Miyazono, Mami
    Hashiguchi, Nobuko
    Sakurada, Harumizu
    Takemoto, Masao
    Mukai, Yasushi
    Inoue, Shujirou
    Sunagawa, Kenji
    Chishaki, Hiroaki
    JOURNAL OF ARRHYTHMIA, 2016, 32 (02) : 102 - 107
  • [27] Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction
    Muhammed, Ahmed
    Abdelazeem, Mohamed
    Elewa, Mohamed Gamaleldin
    Sharief, Mohamed
    Ammar, Ahmed
    HEART FAILURE REVIEWS, 2023, 28 (01) : 229 - 240
  • [28] Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy
    Cavalcanti, Rafael
    Aboul-Hosn, Nael
    Morales, Gustavo
    Abdel-Latif, Ahmed
    ANGIOLOGY, 2018, 69 (04) : 297 - 302
  • [29] Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction
    Ahmed Muhammed
    Mohamed Abdelazeem
    Mohamed Gamaleldin Elewa
    Mohamed Sharief
    Ahmed Ammar
    Heart Failure Reviews, 2023, 28 : 229 - 240
  • [30] Do We Need an Implantable Cardioverter-defibrillator for Primary Prevention in Cardiac Resynchronisation Therapy Patients?
    Katritsis, Demosthenes G.
    Auricchio, Angelo
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2018, 7 (03) : 157 - 158
12345